background: several changes in serum biochemical factors occur in acute myocardial infarction (ami). recently alterations in serum levels of homocysteine (hcy), sialic acid (sa) and high sensitive c-reactive protein (hs-crp) has been attended as risk factors and index for prediction. this study was aimed to show the alterations in these factors and their relationships in ami. methods: thirty fo...

to improve the specificity of biochemical markers of myocardial infarction (mi) a method to measure cardiac troponin-i (ctn-i) was developed. ctn-i is a protein unique to cardiac muscle and is released after mi. consecutive 150 patients admitted to the coronary care unit was studied. value of ctn-i was determined in all samples. ctn-i concentration in the mi patients group was increased compare...

Technetium-99m-pyrophosphate (99mTc-PYP) has been used, in combination with thallium-201, to estimate the site and extent of myocardial infarcts. We report a case of acute myocardial infarction with severe coronary disease in which the distribution of 99mTc-PYP was extensive. A 78-year-old man presented with dyspnea, and a diagnosis of non-ST-segment elevation acute myocar...

background: early clinical investigations indicate that an infusion of autologous bone-marrow cells into the infarct-related coronary artery is feasible after acute myocardial infarction. there is increasing evidence that cell transplantation may improve the perfusion and contractile function of the ischemic myocardium . the present study reports primarily the safety of intracoronary bone marro...

We report an uncommon case of simultaneous cardio-cerebral infarction, due to Inferior – right ventricle ST Segment Elevation Myocardial Infarction (STEMI) with acute ischemic stroke. Incidence cardio cerebral infarction is exceptionally rare, incidence rate as low 0.009%. Hemodynamic compromise in patients myocardial may result the blood flow reduction that cause hemodynamic Due rarity this co...

Wharton’s jelly mesenchymal stem cells (HWJMSCs) hold promise for myocardial regeneration, but optimal treatment regimen (preferably with a growth factor) is required to maximize functional benefits. The aim of this study was to explore the cardioprotective and angiogenesis effects of HWJMSCs combined with insulin-like growth factor-1 (IGF-1) in the treatment of acute myocardial infarction. Th...

Abstract Myocardial infarction is still a therapeutic rollercoaster challenge because, despite revolutionary treatments in its management, heart failure consequence. Stem cell therapy might be turning point treating myocardial patients for regaining what lost—that is, tissue. This paper reviews the latest evidence using stem treatment of infarction, results this possible regarding cardiomyocyte...

background : myocardial infarction in young age is increasing. identifying risk factors could be important for health promotion. we studied classic atherosclerotic risk factors in premature myocardial infarction. methods : in this matched case-control study, which was conducted from 2005 to 2007 in birjand county, the east of iran, atherosclerotic risk factors ( hypertension , family history of...

Brooks NH, et al. ACC/AHA Guidelines for the management of patients with acute myocardial infarction. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: the Primary Angioplasty in Myocar-dial Infarction Study Group. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction: Myocardial Infarction Tri-Clini...